Prominent Cosmetic Dermatologist and Author Joins MySkinCareConn... ( ARLINGTON Va. Feb. 6 -- The Heal...)

Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com

Date:2/6/2008

ARLINGTON, Va., Feb. 6 /PRNewswire-USNewswire/ -- The HealthCentral Network, Inc. (http://www.HealthCentral.com) today announced that Dr. Hema Sundaram, an accomplished dermatologist, cosmetic surgeon and author, is joining the MySkinCareConnection.com community as a skincare and aesthetic medicine expert. Sundaram is the author of Face Value: The Truth About Beauty and A Guilt-Free Guide to Finding It [Rodale], which was honored by the National Press Club. She appears regularly on NBC television and XM radio programming and has been quoted in leading publications including The New York Times, The Chicago Tribune, The Boston Globe, Prevention Magazine, Good Housekeeping, Allure and Cosmopolitan.

A Fellow of the American Academy of Dermatology, Sundaram will be writing twice weekly on a variety of issues, ranging from updates on the latest acne and anti-aging products on the market, to the latest cosmetic trends in pop culture. As a Principle Investigator for the Food and Drug Administration, Sundaram is at the forefront of skin product development and will be writing updates and previews on products for MySkinCareConnection.com, in addition to answering readers' questions.

"I am honored to be joining the HealthCentral team, and I am excited at the opportunity to provide men and women of all ages with informative and thought-provoking insights into the fascinating and fast-paced world of aesthetic medicine and skincare," Sundaram said.

"Hema's extensive experience both in research and in the practice of cosmetic dermatology will serve MySkinCareConnection.com readers well," said Chris Schroeder, CEO and President of The HealthCentral Network. "Not only is she a well respected doctor, she's also a talented writer and journalist -- someone who keeps her finger on the pulse of new treatments and new trends in her field."

Sundaram, who practices dermatology in Maryland and
'/>"/>

SOURCE The HealthCentral Network
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Prominent Health Care Executive, Kevin Kraushaar, Joins Triadvocates LLC as Managing Principal of DC Office
2. Prominent Respiratory Therapist and Author Joins StopSmokingConnection.com as a COPD Expert
3. Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors
4. Prominent Chick Lit Novelist Laura Zigman Joins HealthCentrals MyBreastCancerNetwork.com as Expert
5. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
6. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
7. Acne And Rosacea Getting You Down? Laser, Light And Cosmetic Treatments Give Patients A Much-Needed Boost
8. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
9. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
10. New Low-Impact Cosmetic Surgery Treatments Revolutionizing Industry
11. Donde West Likely Killed by Need to Control Postop Pain After Cosmetic Surgery, States Dr. Barry Friedberg, a Globally Recognized Leader in Cosmetic Surgery Anesthesia.

Post Your Comments:

(Date:11/9/2009)...arkett Sports, the worldwide leader in sports surf...offering with a more complete and innovative range...sports flooring experts and the launch of www.tar...(PRWEB) November 9, 2009 -- Tarkett Sports, redesi... products includes hardwood and synthetic basketba...

(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medi...developer, manufacturer and,marketer of medical de...dited,financial results for the third quarter and ...lights for Operations as of September 30, 2009, ...llion, an increase of, 3.1% over the third q...

(Date:11/9/2009)...RNewswire/ -- The Churchill Centre today announc...p to J.W. "Bill" Marriott for his lifelong commitm...e market practices and fostering an open and trans...receive his award at a ceremony and dinner on Tues...ns Hotel. ,, "This is a testament to how Bill ...

(Date:11/9/2009)...nlargement, study finds , , MONDAY, Nov....tor for left atrial enlargement, which increases t...a new study shows. , Atrial fibrillation is the...t rhythm or heartbeat). , Researchers analyzed...rmany who were followed for 10 years. The study au...

(Date:11/9/2009)...t both eye conditions are age-related, researchers... -- Cataract surgery doesn,t appear to speed the p...D), according to a new study that challenges the b...ns the other. , "Because both conditions are st... also have AMD," wrote Li Ming Dong, of Stony Broo...

[0] Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website [0] Mindray Announces Third Quarter 2009 Financial Results [0] J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership [0] Obesity Seems to Alter Heart Structure [0] Cataract Surgery Doesn't Worsen Macular Degeneration: Study

...visor and speaker Michael Morgan is helping U.S., ...d Middle Eastern and Islamic investors, business, ...ts tap into one of the most active investment sour...ities for everyone to find new markets, partners a...

...HO: Myles Druckman, MD, a leading disease outbr... Dr. Druckman has been interviewed by, ... CNN, CNBC, and, The Washington Post, a... including:, * The WHO raising ...

...r. Joel Selanikio,s innovative technology is not o...ublic health system around the world. Merging his ...ne and public health with his business partner,s b...lth data in developing nations. Officially establi...

...Biosystems, Inc. (OTC Bulletin Board: WGBS), a lea...s systems, today announced the signing of a resear...nter scientists for WaferGen,s SmartChip(TM) Real-... for Genome Sciences and Policy at Duke Universit...

...n and Narrows Earnings Guidance to Upper End of Ra...Hospira, Inc. (NYSE: HSP ), a leading global spe...any, today reported results for the first quarter ...rtain specified items as described later in this p...

...Associates Outlines China ,s , Stimulus Plan a... has announced a $124 billion stimulus package t... calls for digital hospitalization, adoption of el...tual healthcare services that can help overcome di...

Global Advisor and Speaker Explains Middle East Investors, Politics, Culture Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu Open source mobile technology software reinventing health care in developing countries WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System Hospira Reports First-Quarter 2009 Results China Seeks to Transform Healthcare Sector with Information Technology

(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...

(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...

(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...

Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2 ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3 Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6 Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7 BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1 BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2 Research Councils UK sign groundbreaking MoU with Brazil 9928 1 Research Councils UK sign groundbreaking MoU with Brazil 9928 2 Research Councils UK sign groundbreaking MoU with Brazil 9928 3 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4 BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5

[0] ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)[0] Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 [0] Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide

...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...

... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...

Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6 Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7

Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting

FemoStop

VasoSeal VHD KIT 6

VasoSeal VHD KIT 4

Hemapatch Knitted

Medicine Products:

FemoStop VasoSeal VHD KIT 6 VasoSeal VHD KIT 4 Hemapatch Knitted

Prominent Cosmetic Dermatologist and Author Joins MySkinCareConn...( ARLINGTON Va. Feb. 6 -- The Heal...),Health